Related references
Note: Only part of the references are listed.Developments in virus-like particle-based vaccines for infectious diseases and cancer
Luigi Buonaguro et al.
EXPERT REVIEW OF VACCINES (2011)
Long-Term Control of Simian Immunodeficiency Virusmac251 Viremia to Undetectable Levels in Half of Infected Female Rhesus Macaques Nasally Vaccinated with Simian Immunodeficiency Virus DNA/Recombinant Modified Vaccinia Virus Ankara
Mariana Manrique et al.
JOURNAL OF IMMUNOLOGY (2011)
Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody
Dennis R. Burton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
HIV-Gag VLPs presenting trimeric HIV-1 gp140 spikes constitutively expressed in stable double transfected insect cell line
M. Tagliamonte et al.
VACCINE (2011)
Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins
M. L. Visciano et al.
VACCINE (2011)
Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine
Lissette S. Velasquez et al.
VACCINE (2011)
Virus-Like Particles as Particulate Vaccines
Luigi Buonaguro et al.
CURRENT HIV RESEARCH (2010)
Adjuvanted Intranasal Norwalk Virus-Like Particle Vaccine Elicits Antibodies and Antibody-Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues
Samer S. El-Kamary et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Intranasal Administration of Adjuvant-Combined Vaccine Protects Monkeys From Challenge With the Highly Pathogenic Influenza A H5N1 Virus
Takeshi Ichinohe et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
Intranasal Immunization with Influenza VLPs Incorporating Membrane-Anchored Flagellin Induces Strong Heterosubtypic Protection
Bao-Zhong Wang et al.
PLOS ONE (2010)
The Eurocine® L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination
Pernilla Petersson et al.
VACCINE (2010)
Constitutive expression of HIV-VLPs in stably transfected insect cell line for efficient delivery system
M. Tagliamonte et al.
VACCINE (2010)
Intranasal Vaccination with 1918 Influenza Virus-Like Particles Protects Mice and Ferrets from Lethal 1918 and H5N1 Influenza Virus Challenge
Lucy A. Perrone et al.
JOURNAL OF VIROLOGY (2009)
Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination
M. Manrique et al.
MUCOSAL IMMUNOLOGY (2009)
Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope
Susan W. Barnetta et al.
AIDS (2008)
Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant
Mookkan Prabakaran et al.
VIROLOGY (2008)
DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity
L. Buonaguro et al.
VACCINE (2007)
Comparison of intranasal with targeted lymph node immunization using PR8-Flu ISCOM adjuvanted HIV antigens in macaques
G. Koopman et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection
Yasuko Asahi-Ozaki et al.
MICROBES AND INFECTION (2006)
A novel DNA adjuvant, N3, enhances mucosal and systemic immune responses induced by HIV-1 DNA and peptide immunizations
Jorma Hinkula et al.
VACCINE (2006)
Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers
Iain Stephenson et al.
JOURNAL OF VIROLOGY (2006)
Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation
L Buonaguro et al.
JOURNAL OF VIROLOGY (2005)
Immunization with heat-killed Mycobacterium bovis bacille Calmette-Guerin (BCG) in Eurocine™ L3 adjuvant protects against tuberculosis
M Haile et al.
VACCINE (2004)
Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques
A Miyake et al.
JOURNAL OF MEDICAL VIROLOGY (2004)
Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity
C Devito et al.
JOURNAL OF IMMUNOLOGY (2004)
Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men
S Lo Caputo et al.
AIDS (2003)
Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120
RS Veazey et al.
NATURE MEDICINE (2003)
Protection by intranasal immunization of a nef-deleted, nonpathogenic SHIV against intravaginal challenge with a heterologous pathogenic SHIV
Y Enose et al.
VIROLOGY (2002)
Intranasal immunization with SIV virus-like particles (VLPs) elicits systemic and mucosal immunity
QZ Yao et al.
VACCINE (2002)
Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A
L Buonaguro et al.
ANTIVIRAL RESEARCH (2002)
Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses
RA Guerrero et al.
JOURNAL OF VIROLOGY (2001)
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro
PWHI Parren et al.
JOURNAL OF VIROLOGY (2001)
Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza a H5N1 virus infection
TM Tumpey et al.
JOURNAL OF VIROLOGY (2001)
Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1
A Alfsen et al.
JOURNAL OF IMMUNOLOGY (2001)
High efficient production of Pr55(gag) virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A
L Buonaguro et al.
ANTIVIRAL RESEARCH (2001)
Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate
C Devito et al.
AIDS (2000)
Share Paper
